Biocon Limited has informed the Exchange about Qualified Institutions Placement - Approval and adoption the Placement Document dated June 19, 2025
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon Limited's Fund Raising Committee, at a meeting held on June 19, 2025, approved and adopted the Placement Document for a Qualified Institutions Placement (QIP) of equity shares with a face value of ₹5 each. The QIP is being conducted under Chapter VI of the SEBI ICDR Regulations, 2018, and Sections 42, 23(1)(b) and 62(1)(c) of the Companies Act, 2013. This filing follows earlier communications dated June 16, 2025 and June 19, 2025, suggesting the QIP process has been progressing quickly. The committee meeting lasted just 10 minutes (10:20 PM to 10:30 PM), typical for procedural approvals. No details on issue size, pricing, discount/premium to market price, or investor names have been disclosed in this particular filing.
This is a procedural update confirming the QIP is moving forward, but without pricing or size details, shareholders cannot yet assess dilution or valuation impact. Investors should watch for a follow-up disclosure with the issue price and number of shares allotted, which will determine whether the QIP was done at a discount (typically negative for existing shareholders due to dilution) or premium to market price.